|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


* Division of Pulmonary, Allergy and Critical Care, Department of Internal Medicine
School of Nursing
Department of Surgery, University of Minnesota School of Medicine, Minneapolis, MN, U.S.A
kempa001{at}umn.edu
Abstract
BackgroundGastroesophageal reflux disease (GERD) is common in a variety of chronic respiratory diseases, but little is known about GERD in the setting of chronic obstructive pulmonary disease (COPD). The study's aims were to determine the prevalence, presentation, and predictors of GERD based on proximal and distal esophageal pH monitoring in patients with severe COPD.
MethodsForty-one COPD patients with a mean FEV1 of 24% predicted underwent dual probe 24-hour esophageal pH monitoring and 1 patient underwent esophagogastroduodenoscopy.
ResultsThe prevalence of GERD was 57%. Elevated distal and proximal reflux was present in 41% and 46% of patients undergoing esophageal pH studies, respectively. Fifteen percent of these patients had abnormal proximal reflux despite having normal distal probe results. Most patients with GERD were not on acid blockers at the time of their referral, and only one-third reported heartburn and/or acid regurgitation during their pH study. Only higher BMI was predictive of reflux on regression analysis (OR 1.2, 95% CI 1.0, 1.5, p = .05).
ConclusionsGERD is common in advanced COPD. Patients are often asymptomatic and have a relatively high prevalence of isolated abnormal proximal reflux. Dual probe monitoring is therefore well-suited for detecting GERD in patients with advanced COPD.
Key Words: acid-blockers aspiration chronic obstructive pulmonary disease gastroesophageal reflux disease GERD
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |